MedPath

XIMONTH Bee Venom Joint Cream

Approved
Approval ID

33d18888-8d06-da13-e063-6294a90a743c

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 28, 2025

Manufacturers
FDA

Shantou Ximonth Biotechnology Co., Ltd.

DUNS: 457811606

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

GLYCERIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code84989-005
Application NumberM016
Product Classification
M
Marketing Category
C200263
G
Generic Name
GLYCERIN
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 28, 2025
FDA Product Classification

INGREDIENTS (9)

GLYCERINInactive
Quantity: 8 mg in 100 mg
Code: PDC6A3C0OX
Classification: IACT
APIS MELLIFERA VENOMActive
Quantity: 0.02 mg in 100 mg
Code: 76013O881M
Classification: ACTIB
CARBOMER HOMOPOLYMER TYPE AInactive
Quantity: 0.2 mg in 100 mg
Code: F68VH75CJC
Classification: IACT
MINERAL OILInactive
Quantity: 5 mg in 100 mg
Code: T5L8T28FGP
Classification: IACT
GLYCERYL MONOSTEARATEInactive
Quantity: 2 mg in 100 mg
Code: 230OU9XXE4
Classification: IACT
TROLAMINEInactive
Quantity: 0.2 mg in 100 mg
Code: 9O3K93S3TK
Classification: IACT
ALLANTOINInactive
Quantity: 0.02 mg in 100 mg
Code: 344S277G0Z
Classification: IACT
WATERInactive
Quantity: 84.54 mg in 100 mg
Code: 059QF0KO0R
Classification: IACT
MENTHA PIPERITA LEAFActive
Quantity: 0.02 mg in 100 mg
Code: A389O33LX6
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

XIMONTH Bee Venom Joint Cream - FDA Drug Approval Details